Do you mean the improvement in their "likability"?(*) 92% isn't bad--not quite what was advertised, but an improvement.
(*) For historical reference: the Post may correct their subhead, but right now it says "Maccabi health fund releases preliminary results of a study comparing vaccinated and not vaccinated members’ likability to contract the disease and said vaccine 92% effective."
They're doing a fantastic job, as usual. The 92% figure isn't their doing, that's just news about whether the immunity suggested by the trials will be borne out in the larger-scale public rollout, not in Israel's control. What Israel does deserve credit for is vaccinating so many people so fast, and getting us decent data right away.
Do you mean the improvement in their "likability"?(*)
ReplyDelete92% isn't bad--not quite what was advertised, but an improvement.
(*) For historical reference: the Post may correct their subhead, but right now it says "Maccabi health fund releases preliminary results of a study comparing vaccinated and not vaccinated members’ likability to contract the disease and said vaccine 92% effective."
They're doing a fantastic job, as usual. The 92% figure isn't their doing, that's just news about whether the immunity suggested by the trials will be borne out in the larger-scale public rollout, not in Israel's control. What Israel does deserve credit for is vaccinating so many people so fast, and getting us decent data right away.
ReplyDelete